Effects of coronary vasodilator drugs on the uptake and release of adenosine in cardiac cells
- 1 September 1979
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 28 (17), 2617-2624
- https://doi.org/10.1016/0006-2952(79)90037-6
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Effect of dipyridamole on myocardial adenosine metabolism and coronary flow in hypoxia and reactive hyperemia in the isolated perfused guinea pig heartJournal of Molecular and Cellular Cardiology, 1976
- Cyclic Nucleotide Phosphodiesterases: Properties, Activators, Inhibitors, Structure–Activity Relationships, and Possible Role in Drug DevelopmentJournal of Pharmaceutical Sciences, 1975
- Relationship between coronary flow and adenosine production and releaseJournal of Molecular and Cellular Cardiology, 1974
- Steric requirements for binding of adenosine to a membrane carrier in canine heartBiochimica et Biophysica Acta (BBA) - Biomembranes, 1973
- The effect of adenosine on cardiac cells in cultureJournal of Molecular and Cellular Cardiology, 1972
- DIFFERENCES AMONG DIPYRIDAMOLE, CARBOCHROMEN AND LIDOFLAZINE IN RESPONSES OF THE CORONARY AND THE RENAL ARTERIESThe Japanese Journal of Pharmacology, 1972
- Inhibition of Hypoxia-Induced Rise in Adenosine Release and Flow by Coronary DilatorsCardiology, 1971
- Influence of dipyridamol (Persantin) on myocardial adenosine metabolismJournal of Molecular and Cellular Cardiology, 1970
- Potentiation of Adenosine Activity by Low Oral Doses of LidoflazineNature, 1969
- Enhancement of Coronary Vasodilating Action of ATP and Adenosine by LidoflazineCirculation Research, 1968